Sarepta Therapeutics (SRPT): Down 50%
Sarepta Therapeutics Inc. (NASDAQ:SRPT) is a commercial-stage biotechnology company engaged in developing unique RNA-targeted therapies and gene therapies for treating rare diseases. It is currently working...
Sarepta Therapeutics Inc. (SRPT)
Get Email AlertsSector: Pharmaceutical Preparations
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | VenBio Select Advisor Kurt Von Emster | 1,750,000 | $298,358 | +5% | 5.13% |
| 2. | 68,497,000 | $167,487 | -20% | 0.04% | |
| 3. | 870,900 | $148,481 | +65% | 6.54% | |
| 4. | 59,662,000 | $145,743 | -4% | 3.84% | |
| 5. | Farallon Capital Thomas Steyer | 600,000 | $102,294 | 0.66% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $87.49 | 3,309 | Director | 3,187,065 | 2019-09-13 | Filing | |
| $87.49 | 1,691 | Director | 3,183,756 | 2019-09-12 | Filing | |
| $86.74 | 2,000 | Director | 7,051 | 2019-09-09 | Filing | |
| $87.98 | 2,500 | Director | 125,667 | 2019-09-06 | Filing | |
| $99.32 | 5,000 | Director | 3,182,065 | 2019-08-20 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $165.00 | 1,115 | Officer | 8,140 | 2020-12-11 | Filing | |
| $160.00 | 1,125 | Officer | 8,140 | 2020-12-08 | Filing | |
| $159.65 | 777 | Director | 13,792 | 2020-08-10 | Filing | |
| $158.95 | 9,223 | Director | 14,569 | 2020-08-10 | Filing | |
| $159.09 | 3,140 | Director | 3,129,140 | 2020-08-07 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 406,555 | $69,313,563 | 0.03% | |
| 2. | 9,407,000 | $23,034,356 | 0.05% | |
| 3. | 30,929 | $5,273,085 | 0.04% | |
| 4. | 26,510 | $4,519,690 | 0.01% | |
| 5. | 7,736,748 | $1,319,041 | 0.34% |
News See All
Is SRPT A Good Stock To Buy Now According To Hedge Funds?
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows their positions at the end of every quarter. Even...
12 Best Large Biotech Stocks to Buy Now
Biotech companies are research science-driven companies focusing on novel drug development and clinical research with aims to treat diseases and medical conditions. Biotech stocks are popular among investors...
Sarepta Therapeutics Inc (SRPT): Are Hedge Funds Right About This Stock?
We know that hedge funds generate strong, risk-adjusted returns over the long run, therefore imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors...
Hedge Funds Are Crazy About Sarepta Therapeutics Inc (SRPT)
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. We at Insider Monkey have plowed through 823 13F...
Did Hedge Funds Make The Right Call On Sarepta Therapeutics Inc (SRPT) ?
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors...
Is Sarepta Therapeutics Inc (SRPT) Going to Burn These Hedge Funds?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. Insider Monkey finished processing 821 13F filings...
Do Hedge Funds Love Sarepta Therapeutics Inc (SRPT)?
Coronavirus is probably the #1 concern in investors’ minds right now. It should be. On February 27th we published this article and predicted that a US recession is imminent and US stocks will go down...
How Did Sarepta Therapeutics Inc (SRPT) Compare Against Top Hedge Fund Stocks in 2019?
Hedge funds and other investment firms that we track manage billions of dollars of their wealthy clients' money, and needless to say, they are painstakingly thorough when analyzing where to invest this...
Did Hedge Funds Drop The Ball On Sarepta Therapeutics Inc (SRPT) ?
Our extensive research has shown that imitating the smart money can generate significant returns for retail investors, which is why we track nearly 750 active prominent money managers and analyze their...
Billionaire Hedge Funds
